InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.55
(
-0.25%
)
US TECH 100
19,238.40
(
-0.88%
)
Dow Jones
39,108.19
(
0.70%
)
Brent Oil
85.10
(
0.47%
)
Bitcoin
64,917.90
(
-0.07%
)
Post# of 252271
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: turtlepower post# 88895

Monday, 01/31/2011 11:46:36 AM

Monday, January 31, 2011 11:46:36 AM

Post# of 252271
Allergan Inc (AGN.N) bought co-promotion rights on Map Pharmaceuticals Inc's (MAPP.O) experimental treatment for acute migraine for $60 million in upfront payment, in a move to expand its migraine franchise.

The two companies will co-promote the drug, Levadex, to neurologists and pain specialists in the United States, pending regulatory approval.

http://www.reuters.com/article/2011/01/31/allergan-idUSSGE70U0CE20110131?feedType=RSS&feedName=rbssHealthcareNews&rpc=43
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up